Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel with or without Bevacizumab in First-Line Metastatic Breast Cancer
NCT00028990Phase 3Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Jan 2002
- Primary completion
- Nov 2006
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 3 trial of bevacizumab in breast cancer, sponsored by Eastern Cooperative Oncology Group. Started Jan 2002; status: completed.
02
Drugs
bevacizumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00028990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00028990.